Education Blog for Healthcare Professionals

Archive for the ‘Other topics’ Category

ASH 2014 Highlights: Thrombosis and Anticoagulation

| Other topics, Uncategorized | Comments Off on ASH 2014 Highlights: Thrombosis and Anticoagulation

Stephan Moll, MD writes... The annual American Society of Hematology (ASH) meeting took place in Dec 2014 in San Francisco.  A summary of the clinically relevant thrombosis and anticoagulation presentation and abstracts is presented here (Top 10 ASH Highlights).

 

Disclosure: I have been a consultant to Portola, Daiichi, Janssen, and Boehringer-Ingelheim. 

Last updated: Jan 27th, 2015

Top 10 Publications on Thrombosis and Anticoagulation from 2012

| Arterial Clots, Aspirin, Plavix, Aggrenox, Tiklid, Persantine, Deep Vein Thrombosis (DVT), Eliquis, Other topics, Pradaxa (dabigatran), Pulmonary Embolism, Uncategorized, Venous Clots, Warfarin (Coumadin), Xarelto (Rivaroxaban) | Comments Off on Top 10 Publications on Thrombosis and Anticoagulation from 2012

Stephan Moll writes…

2012 has been a year with significant progress in the field of venous thromboembolism and anticoagulation.  The three most noteworthy, clinically relevant developments were probably (a) the publication of the new ACCP (American College of Chest Physician) guidelines on antithrombotic therapy in February 2012; (b)  The FDA-approval of rivaroxaban (Xarelto) in November 2012 for the acute treatment of venous thromboembolism (VTE) and long-term secondary prevention; and (c) The FDA-approval of apixaban (Eliquis) in December 2012 for atrial fibrillation and the prevention of arterial thromboembolism.  Here I have listed and summarized the 10 top publications of 2012  in the field of venous thromboembolism and anticoaguation as I see them – the ones clinically most relevant. 

 

Disclosure: I have consulted for Janssen, Boehringer-Ingelheim and Daiichi.

Last updated: Feb 7th, 2013

 

ASH 2011: Highlights in Thrombosis and Anticoagulation

| Other topics, Uncategorized | Comments Off on ASH 2011: Highlights in Thrombosis and Anticoagulation

The annual meeting of the American Society of Hematology (ASH) took place in San Diego from Dec 10-13, 2011.  Abstracts on thrombosis and anticoagulation that I found  interesting and clinically relevant  are summarized and put into a clinical perspective in this summary document.  Only one abstract was, in my assessment, clinical-practice-changing – abstract #543: “Aspirin after oral anticoagulants for prevention of recurrence in patients with unprovoked VTE. The WARFASA study”.  It is the first abstract discussed in the summary document.

 

Disclosure:  I have no conflict of interest relevant to this post.

Last updated: Dec 13th, 2011